SHP Wealth Management’s Biogen BIIB Stock Holding History

SHP Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46K	Sell	213 -29	-12%	-$5.55K	﹤0.01%	570
2026 Q1	$44.3K	Buy	242 +19	+9%	+$3.5K	﹤0.01%	521
2025 Q4	$39.2K	Buy	+223	New	+$36.4K	﹤0.01%	535

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SHP Wealth Management's BIIB Position: Q2 2026 in Review

SHP Wealth Management reduced its Biogen (BIIB) stake by 12% in Q2 2026, selling an estimated $5.55K and leaving 213 shares worth $46K. The position accounts for ﹤0.01% of the portfolio, ranked #570.

SHP Wealth Management first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

SHP Wealth Management held 213 shares of Biogen worth $46K as of Q2 2026.
SHP Wealth Management sold 29 Biogen shares in Q2 2026, an estimated $5.55K.
Biogen made up ﹤0.01% of SHP Wealth Management's portfolio in Q2 2026, its #570 holding.
SHP Wealth Management first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on SHP Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.